Research, Science & Development

The findings, generated using patient-derived stem cells and advanced brain models, could support the development of targeted therapies for Huntington’s disease, which progressively damages movement, cognitive function and behavioural control.

Researchers presented the findings at the 26th International AIDS Conference in Rio de Janeiro, Brazil.

The new service automates coxometry, a process that involves identifying specific anatomical landmarks and calculating angles to assess the position and alignment of structures within the hip joint.

The United Nations (UN) and the International Telecommunication Union (ITU) organised the summit as a platform for advancing practical AI solutions that support the Sustainable Development Goals.

The EBO-PEP platform trial, which has been under development since 2024, will evaluate several medicines as post-exposure prophylaxis for people who have had high-risk contact with filoviruses, the virus family that includes Bundibugyo Ebola.

The study will use the Dexcom G7 Continuous Glucose Monitoring system, developed by a global leader in CGM technology, to assess whether continuous monitoring can improve blood sugar control when integrated into a structured, multidisciplinary care programme.

MindRank developed MAP as an AI-native drug discovery engine that combines computational biology, chemistry, laboratory experiments and clinical data into a single research platform.

Under the agreement, researchers will gain access to an integrated platform that combines Evogene’s AI-powered computational chemistry engine, ChemPass AI, with the BCDD’s laboratory infrastructure and drug discovery expertise.

Researchers will use GE HealthCare’s StarGuide SPECT/CT imaging system together with MIM Software’s MIM LesionID Pro platform to monitor how tumours respond throughout treatment.